Group 1 - The core point of the news is that E Fund Management Co., Ltd. has reduced its stake in Tiger Med (03347.HK) by selling 161,500 shares at an average price of HKD 47.6128 per share, amounting to approximately HKD 7.6895 million [1][2] - After the reduction, E Fund's total shareholding in Tiger Med is now 9,762,400 shares, which represents a decrease in ownership percentage from 8.06% to 7.93% [1][2]

Core Viewpoint - The company is planning to revise its internal regulations and amend its articles of association to enhance corporate governance and compliance with legal requirements [2][26][29]. Group 1: Company Governance Changes - The company will no longer have a supervisory board, with its functions being transferred to the audit committee of the board of directors [26][29]. - Amendments to the articles of association and internal regulations are aimed at improving operational standards and governance [2][26][29]. Group 2: Shareholder Meeting Details - The company will hold its first extraordinary general meeting of 2025 on October 16, 2025, with both on-site and online voting options available [6][10][41]. - The record date for shareholders to attend the meeting is set for October 10, 2025 [8][10]. - Shareholders can register for the meeting through various methods, including in-person and electronic means [11][13][14]. Group 3: Voting Procedures - Voting will be conducted through the Shenzhen Stock Exchange trading system and an internet voting platform, with specific time slots designated for each [18][20]. - The voting process will require shareholders to choose between on-site and online voting, with only one method allowed per shareholder [7][10][20]. Group 4: Internal Regulation Revisions - The company has proposed revisions to several internal regulations, including rules for shareholder meetings, board meetings, and independent director systems, all of which have been approved by the board [29][30][41]. - The revised internal regulations will be submitted for approval at the upcoming extraordinary general meeting [2][41].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002622 证券简称：皓宸医疗 公告编号：2025-024 皓宸医疗科技股份有限公司 关于修订《公司章程》及公司部分内部制度的公告 本公司董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 ■ （一）将"股东大会"调整为"股东会"； （二）删除监事会、监事相关规定，由董事会审计委员会行使《公司法》规定的监事会职权； （三）新增"控股股东和实际控制人"章节； （四）新增"独立董事"章节； （五）新增"董事会专门委员会"章节； （六）将股东会股东提案权所要求的持股比例由3%降至1%。 一、关于《公司章程》修订情况 根据《中华人民共和国公司法》（以下简称"《公司法》"）《上市公司章程指引》《关于新〈公司法〉 配套制度规则实施相关过渡期安排》等法律法规及规范性文件的规定，结合公司实际情况，公司拟不再 设置监事会，监事会的职权由董事会审计委员会行使，同时，公司《监事会议事规则》相应废止，公司 各项规章制度中涉及监事会、监事的规定不再适用。 本次事项尚需提交公司股东大会审议，同时提请股东大会授权公司经营管理层办理工商变更登 ...

医渡科技(02158)发布公告，于2025年9月29日斥资192.71万港元回购33.5万股股份。 ...

Core Viewpoint - The article emphasizes the significance of hard technology innovation as a core driver for reshaping competitive landscapes, leading industrial transitions, and addressing critical challenges in key sectors such as semiconductors, high-end equipment, and new energy [2]. Group 1: Evaluation Process - The evaluation process for the "Hard Technology Innovators" selection took three months, attracting over a hundred early-stage companies through active applications and recommendations from investment institutions [3]. - The assessment was based on three dimensions: technological and product achievements, commercial value and potential, and the influence of founding teams, utilizing a composite review model [3]. - A total of 44 companies were selected for the "2025 Worthy of Attention Hard Technology Innovators" list, with notable companies advancing to the final showcase event [3]. Group 2: Awarded Companies Overview - Among the awarded companies, 25 are in the smart manufacturing sector, focusing on sub-sectors like new energy batteries, new materials, semiconductors, and advanced equipment [5]. - The average establishment age of the awarded companies is three years, with 52% founded within one to three years [5]. - The top three regions for awarded companies are Beijing, Zhejiang, and Jiangsu, with a concentration of talent and entrepreneurial activity in these areas [5]. Group 3: Team Background - 24 awarded companies have core teams with overseas study backgrounds, and over 90% of founders hold master's degrees or higher, with nearly 70% possessing doctoral degrees [6]. - Notable educational institutions represented among founders include Tsinghua University, Fudan University, and Peking University [6]. Group 4: Financing Situation - 86% of awarded companies have historical financing records, indicating a trend towards attracting more early-stage and industrial capital as technology matures [7].

今海医疗科技(02225)发布公告，郑远女士已辞任(i)公司的公司秘书，(ii)授权代表，及(iii)法律程序代理 人，由2025年9月29日起生效。 黄文耀先生已获委任为公司秘书、授权代表及法律程序代理人，自2025年9月29日起生效，以填补郑女 士辞任后的空缺。 ...

2025年9月16日，山东步长制药股份有限公司第五届董事会第三十二次会议通过议案，其控股子公司上 海合璞医疗科技有限公司拟共投资490万元，分别与济南恒德科技、上海裹鼎科技设立山东合璞锐诚医 疗科技有限公司、湖北合璞医疗科技有限公司，上海合璞均持股70%。近日，两家新公司完成工商登记 注册手续。山东合璞锐诚医疗科技注册资本400万元，9月24日成立；湖北合璞医疗科技注册资本300万 元，9月26日成立。相关信息已在上海证券交易所网站披露。 ...

Core Insights - The 6th China Liaoning International Investment and Trade Fair (Liaoning Fair) was held from September 25 to 28, 2023, in Shenyang, serving as a significant platform for expanding Liaoning's international cooperation and trade [3][4] - The fair attracted over 60 countries' officials, business leaders, and representatives from Fortune 500 companies, highlighting its importance in fostering global economic ties [4] Group 1: Investment and Trade Opportunities - The fair showcased various products, including an AI-assisted pathology image analysis system, indicating a focus on technological advancements in healthcare [3] - Japanese enterprises have consistently participated in the fair, signing cooperation agreements with Chinese food companies, demonstrating effective international collaboration [3] - The presence of South Korean companies, such as the automotive filter manufacturer, reflects the fair's role in facilitating business expansion and partnerships in the region [3] Group 2: Economic Growth and Foreign Investment - Liaoning's geographical advantages, including its location in the Northeast Asia economic circle and its role in the Belt and Road Initiative, enhance its appeal for foreign investment [3] - In the first half of the year, Liaoning attracted $2.87 billion in foreign direct investment, marking a 126.3% year-on-year increase [5] - The province's total import and export value reached 501.94 billion yuan in the first eight months, with exports hitting a record high of 267.67 billion yuan, reflecting robust economic performance [5]

"卓睦鸟医疗大模型"不仅是一个技术产品，更是一个贯穿健康服务全链路的智能引擎。中康科技在2025 年3月发布的"医疗健康全场景智能体"，正是依托天宫一号和卓睦鸟医疗中台两大引擎，结合行业高质 量数据、专业知识和领先的大模型蒸馏技术，打造出围绕商用、医疗、药店、健康管理和研发多场景智 能化体解决方案，这些智能体能够实现"智能决策、敏捷行动、结果可控"的业务闭环，帮助医疗健康行 业提升效率与服务质量。 "卓睦鸟医疗大模型"依托中康科技在健康产业近二十年的数据积累与行业洞察，构建了覆盖百万级医学 文献、指南、教材、药品说明书等公开语料，以及千万级脱敏临床数据、病种记录与非结构化病历的高 质量训练资源。模型参数量达700亿，通过大规模预训练与多阶段指令微调，结合数据清洗、去重、增 强等先进工艺，不断提升其在真实医疗场景中的泛化能力与响应精度。 近日，国内权威医疗大模型评测平台MedBench发布2025年度最新测评结果。在新一轮测评中，中康科 技"卓睦鸟医疗大模型"再次脱颖而出，勇夺榜单综合排名第2、医学语言理解单项排名第1的亮眼成绩， 彰显其在自然语言处理与医疗专业知识深度融合方面的显著优势。 ...

想象一下去医院看病，人工智能（AI）系统根据患者的检查数据实时自动生成治疗方案，经医生审查后，如果患者和医生皆不反对就直接执行该方案—— 这不是科幻，而是中国医学科学院血液病医院（中国医学科学院血液学研究所）信息与资源中心首席技术专家陈俊仁和姜尔烈团队的最新技术突破。近日， 上述团队在《自然·通讯》杂志发表文章，首次报道条件式自主AI开立药物处方的临床实践。 陈俊仁表示，当前AI的临床医学应用多是"辅助型AI"。好比社交平台的智能引擎推送个性化的新闻信息，辅助型的医疗AI基于患者情况生成个性化的医学 专业信息，接着医生和患者决定是否采纳该信息并共同决定如何根据AI所提供的信息制定诊治方案。 然而，随着AI迅速深入到人类日常生活的多个方面，条件式自主AI模式也越来越普遍。例如汽车驾驶导航软件不仅提供空间地图信息和实时路况，而且可 直接计算出最优驾驶路线。 研究团队认为，未来AI临床应用也可能采取条件式自主模式，即AI制定医疗方案作为默认选项，若医生和患者不否决就执行该默认方案。研究团队假设， 在满足三个条件的情况下，医生和患者更可能愿意接受使用条件式自主AI生成医疗方案：一、除了AI手段之外没有其他方法能精准判 ...